Compounds > beclobrate
Page last updated: 2024-08-23

beclobrate and Hyperlipoproteinemia Type II

beclobrate has been researched along with Hyperlipoproteinemia Type II in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avogaro, P; Bittolo Bon, G; Bufalino, L; Cazzolato, G; Soldan, S1
Ljachnicky, N; Uglesić, A1

Trials

2 trial(s) available for beclobrate and Hyperlipoproteinemia Type II

ArticleYear
A cross-over controlled study on beclobrate versus bezafibrate in the treatment of type IIb hyperlipoproteinaemia.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:6-7

    Topics: Adult; Aged; Benzhydryl Compounds; Bezafibrate; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Randomized Controlled Trials as Topic

1989
[Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1988, Jul-05, Volume: 77, Issue:27-28

    Topics: Aged; Benzhydryl Compounds; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged; Triglycerides

1988